Publication | Open Access

Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine

Alzheimer's DiseaseMedicineDementiaPharmacological AgentNeuropharmacologyNeurochemical BiomarkersMultipotent MaoPharmacotherapyNeurologyNeuroscienceCycloalkyl Propargyl AmineCholinesterase InhibitorsPharmacologyTreatmentDrug DiscoveryLewy Body Dementia